1. Home
  2. OSRHW vs EICC Comparison

OSRHW vs EICC Comparison

Compare OSRHW & EICC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSRHW
  • EICC
  • Stock Information
  • Founded
  • OSRHW N/A
  • EICC N/A
  • Country
  • OSRHW United States
  • EICC United States
  • Employees
  • OSRHW 21
  • EICC N/A
  • Industry
  • OSRHW
  • EICC
  • Sector
  • OSRHW
  • EICC
  • Exchange
  • OSRHW Nasdaq
  • EICC Nasdaq
  • Market Cap
  • OSRHW N/A
  • EICC N/A
  • IPO Year
  • OSRHW 2023
  • EICC N/A
  • Fundamental
  • Price
  • OSRHW $0.05
  • EICC $25.20
  • Analyst Decision
  • OSRHW
  • EICC
  • Analyst Count
  • OSRHW 0
  • EICC 0
  • Target Price
  • OSRHW N/A
  • EICC N/A
  • AVG Volume (30 Days)
  • OSRHW N/A
  • EICC 18.7K
  • Earning Date
  • OSRHW N/A
  • EICC 01-01-0001
  • Dividend Yield
  • OSRHW N/A
  • EICC 7.96%
  • EPS Growth
  • OSRHW N/A
  • EICC N/A
  • EPS
  • OSRHW N/A
  • EICC 0.55
  • Revenue
  • OSRHW N/A
  • EICC $51,224,692.00
  • Revenue This Year
  • OSRHW N/A
  • EICC $39.61
  • Revenue Next Year
  • OSRHW N/A
  • EICC $27.28
  • P/E Ratio
  • OSRHW N/A
  • EICC $23.44
  • Revenue Growth
  • OSRHW N/A
  • EICC 68.61
  • 52 Week Low
  • OSRHW N/A
  • EICC $23.75
  • 52 Week High
  • OSRHW N/A
  • EICC $25.25
  • Technical
  • Relative Strength Index (RSI)
  • OSRHW N/A
  • EICC 60.83
  • Support Level
  • OSRHW N/A
  • EICC $25.04
  • Resistance Level
  • OSRHW N/A
  • EICC $25.15
  • Average True Range (ATR)
  • OSRHW 0.00
  • EICC 0.09
  • MACD
  • OSRHW 0.00
  • EICC 0.01
  • Stochastic Oscillator
  • OSRHW 0.00
  • EICC 97.18

About OSRHW OSR Holdings Inc. Warrant

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

About EICC Eagle Point Income Company Inc. 8.00% Series C Term Preferred Stock due 2029

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: